Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
As of close of business last night, Shattuck Labs Inc’s stock clocked out at $4.15, down -4.82% from its previous closing price of $4.36. In other words, the price has decreased by -$4.82 from its previous closing price. On the day, 5.58 million shares were traded. STTK stock price reached its highest trading level at $4.4058 during the session, while it also had its lowest trading level at $4.065.
Ratios:
To gain a deeper understanding of STTK’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.00 and its Current Ratio is at 17.00. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
On September 08, 2025, Wedbush started tracking the stock assigning a Outperform rating and target price of $4.
On March 17, 2025, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $4.Leerink Partners initiated its Outperform rating on March 17, 2025, with a $4 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 25 ’25 when ORBIMED ADVISORS LLC bought 6,306,127 shares for $0.87 per share. The transaction valued at 5,471,826 led to the insider holds 5,255,106 shares of the business.
Ashiya Mona bought 6,306,127 shares of STTK for $5,471,826 on Aug 25 ’25. The Director now owns 5,255,106 shares after completing the transaction at $0.87 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, STTK now has a Market Capitalization of 262611360 and an Enterprise Value of 179109344. For the stock, the TTM Price-to-Sale (P/S) ratio is 262.61 while its Price-to-Book (P/B) ratio in mrq is 2.81. Its current Enterprise Value per Revenue stands at 179.109 whereas that against EBITDA is -3.327.
Stock Price History:
The Beta on a monthly basis for STTK is 1.53, which has changed by 2.6403508 over the last 52 weeks, in comparison to a change of 0.15024745 over the same period for the S&P500. Over the past 52 weeks, STTK has reached a high of $4.89, while it has fallen to a 52-week low of $0.69. The 50-Day Moving Average of the stock is 29.86%, while the 200-Day Moving Average is calculated to be 135.50%.
Shares Statistics:
It appears that STTK traded 376.08K shares on average per day over the past three months and 1133720 shares per day over the past ten days. A total of 63.15M shares are outstanding, with a floating share count of 49.63M. Insiders hold about 21.57% of the company’s shares, while institutions hold 47.55% stake in the company. Shares short for STTK as of 1767139200 were 1028366 with a Short Ratio of 2.73, compared to 1764288000 on 669432. Therefore, it implies a Short% of Shares Outstanding of 1028366 and a Short% of Float of 2.16.
Earnings Estimates
The market rating for Shattuck Labs Inc (STTK) is a result of the insights provided by 5.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.11 and low estimates of -$0.17.
Analysts are recommending an EPS of between -$0.54 and -$0.98 for the fiscal current year, implying an average EPS of -$0.75. EPS for the following year is -$0.52, with 5.0 analysts recommending between -$0.3 and -$0.71.
Revenue Estimates
A total of 5 analysts have provided revenue estimates for STTK’s current fiscal year. The highest revenue estimate was $2M, while the lowest revenue estimate was $1k, resulting in an average revenue estimate of $1M. In the same quarter a year ago, actual revenue was $5.72M
